Recombinant Vibrio vulnificus 23S rRNA (uracil (1939)-C (5))-methyltransferase RlmD (rlmD)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is finalized during production. If you require a specific tag, please inform us for preferential development.
Synonyms
rlmD; rumA; VV2822; 23S rRNA; uracil(1939)-C(5))-methyltransferase RlmD; EC 2.1.1.190; 23S rRNA(m5U1939)-methyltransferase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-438
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Vibrio vulnificus (strain YJ016)
Target Names
rlmD
Target Protein Sequence
MARFFQPKKK LQPESKHQQV LVEKLDHQGA GIAYLNKKPL FIDGTLPGEE VVTQLTESKS KFARGKLIKL LKPAAERVEP FCSHFNQCGG CDMQHMDYQA QLAYKQRTLL QLMKKFSGSE ILLSPPVTGL EKAYRRRARV SLMWDKKSRQ LQFGFRRKQS KQIENVTQCP VLVAELECLL PELKAILSHF HHPEHLGHVE LVAADNGAVI TLRHTGPLLD EDVAKLRQCA EQHQATLYLM PASDQLERIS GEAPYYQEIG FKVPFEPNNF IQVNQKVNQQ MVVQALEWLD PQSSDRVLDL FCGLGNFSLP IASKAKSVTG VEGVDDMVQK AALNASLNQI NNAQFFHANL EQDFVGQPWA SEKFDKILLD PARAGASGII EQVSALGAKR VVYVSCNPAT LARDSQSLLE QGYRLTKLGM LDMFPYTSHL ESMALFEK
Uniprot No.

Target Background

Function

This recombinant protein catalyzes the formation of 5-methyl-uridine at position 1939 (m5U1939) in 23S rRNA.

Database Links

KEGG: vvy:VV2822

Protein Families
Class I-like SAM-binding methyltransferase superfamily, RNA M5U methyltransferase family, RlmD subfamily

Q&A

What is Vibrio vulnificus 23S rRNA (uracil(1939)-C(5))-methyltransferase RlmD and what is its function?

RlmD (also known as rumA) is an S-adenosyl-methionine (SAM) dependent methyltransferase that catalyzes the formation of 5-methyluridine (m5U) at position 1939 in 23S ribosomal RNA. This enzyme specifically methylates the C5 position of uracil, playing a critical role in post-transcriptional modification of rRNA. The enzyme belongs to the COG2265 cluster of methyltransferases and is widely distributed across bacterial species .

The RlmD protein from Vibrio vulnificus (strain YJ016) is a full-length protein of 438 amino acids. The amino acid sequence includes specific domains for RNA substrate recognition and catalytic activity .

How does RlmD differ from other rRNA methyltransferases?

RlmD is specific for the U1939 position in 23S rRNA, while related methyltransferases target different positions. For instance, in Escherichia coli, three paralogues exist within the COG2265 cluster:

  • TrmA: targets U54 in tRNAs

  • RlmC: modifies U747 in 23S rRNA

  • RlmD: specific for U1939 in 23S rRNA

Interestingly, in Bacillus subtilis, a single enzyme called YefA (renamed RlmCD) can catalyze both m5U747 and m5U1939 modifications in 23S rRNA, suggesting evolutionary changes in target specificity among COG2265 enzymes . This divergence in function highlights that RlmD has undergone specialization during bacterial evolution.

What are the key structural features of RlmD that enable its specific methyltransferase activity?

RlmD contains several key structural features essential for its methyltransferase activity:

  • A Rossmann-fold methyltransferase domain for SAM binding and catalytic activity

  • Target recognition domains (TRDs) that enable specific binding to rRNA

  • Positively charged surface patches that facilitate interaction with the negatively charged RNA substrate

As observed in related methyltransferases, the catalytic domain likely creates an open and shallow SAM-binding site, suggesting that the RNA substrate may be required for tight cofactor binding .

How does RlmD recognize its specific target site in 23S rRNA?

RlmD employs a combination of mechanisms to recognize its specific target site:

  • The positively charged surface patches vary among different modification enzymes, reflecting their distinct substrate selectivity.

  • Additional domains fused to the catalytic domain (known as target recognition domains or TRDs) endow RlmD with higher specificity and affinity for the target nucleotide.

  • Some evidence suggests that early-acting modification enzymes like RlmD contain larger, separate TRDs in addition to the catalytic domain, while late-stage enzymes that recognize assembled ribosomal subunits are often single-domain proteins .

The pattern of substrate recognition has implications for experimental design, as in vitro studies may require specific structural contexts of the rRNA for proper RlmD activity.

What expression systems are recommended for producing recombinant RlmD?

Multiple expression systems have been used successfully for producing recombinant RlmD, each with distinct advantages:

Expression SystemTag OptionsSpecial FeaturesConsiderations
E. coliVarious tags availableHigh yield, economicalMay require optimization for solubility
YeastVarious tags availablePost-translational modificationsLower yield than E. coli
BaculovirusVarious tags availableComplex eukaryotic processingMore expensive, longer production time
Mammalian cellsVarious tags availableHighest authenticity for complex proteinsMost expensive, lowest yield

For most research applications, E. coli-based expression is sufficient and provides good yields. For specific applications requiring biotinylation, an Avi-tag system with E. coli biotin ligase (BirA) technology can be employed for in vivo biotinylation .

What methods can be used to assess RlmD activity in vitro?

Several methodological approaches can be used to assess RlmD methyltransferase activity:

  • HPLC Analysis: After enzymatic reaction, rRNA can be digested and analyzed by HPLC to detect the presence of methylated nucleotides. This allows for quantitative assessment of the conversion of uridine to 5-methyluridine.

  • Two-dimensional Thin Layer Chromatography (2D-TLC): This method provides better detection of modified nucleotides when peaks are difficult to separate by HPLC alone .

  • RNase T2 Digestion Analysis: RNase T2 produces ribonucleotide 3′-monophosphates (Np) that can be analyzed to identify specific methylation sites. This approach can help determine if the methylation is complete under experimental conditions .

  • Radiolabeling Approaches: Using [α-32P]CTP-labeled RNA substrates followed by enzyme treatment and TLC analysis can reveal the presence of specific modifications .

How does RlmD contribute to bacterial stress adaptation and survival?

Research on related bacterial species suggests RlmD plays an important role in stress adaptation:

  • In Vibrio cholerae, experimental evolution studies have shown that stress conditions lead to genetic modifications in genes encoding second messenger molecules that regulate biochemical pathways implicated in stress survival .

  • These stress conditions (including iron excess/limitation, low pH, oxidative stress, and osmotic stress) mimic both the gut environment and environmental conditions outside the human host, suggesting RlmD modifications may help pathogens adapt to diverse environments .

  • RNA modifications, including those catalyzed by methyltransferases like RlmD, can affect ribosome assembly, function, and potentially contribute to antimicrobial resistance mechanisms .

The modifications in 23S rRNA likely provide structural stability to ribosomes under stress conditions, allowing bacteria to maintain protein synthesis even in challenging environments.

What is the relationship between RlmD activity and antimicrobial resistance?

Studies indicate potential connections between RlmD activity and antimicrobial resistance:

  • In Vibrio vulnificus EPL 0201 biotype 2, whole-genome analysis revealed the presence of resistance genes against multiple antibiotics including cephalosporins, aminoglycosides, tetracyclines, and sulfonamides, suggesting potential connections between rRNA modifications and resistance mechanisms .

  • The metabolic network analysis of V. vulnificus CMCP6 identified RlmD as a potential drug target based on metabolite essentiality criteria, indicating its importance in bacterial metabolism and potential vulnerability to antimicrobial intervention .

  • Modifications in rRNA, including those catalyzed by RlmD, can affect ribosome structure and function, potentially interfering with the binding of antibiotics that target the ribosome .

How can RlmD be used in a systems biology approach for drug target identification?

RlmD can be integrated into systems biology approaches for identifying novel drug targets:

  • Genome-scale Metabolic Network Analysis: As demonstrated with V. vulnificus CMCP6, reconstructing genome-scale metabolic networks (like VvuMBEL943 with 943 reactions and 765 metabolites) allows systematic prediction of drug targets, including enzymes like RlmD .

  • Metabolite Essentiality Concept: This approach identifies critical metabolites essential for bacterial survival, and then targets the enzymes that interact with these metabolites .

  • Experimental Validation: Predicted targets should be experimentally validated using gene knockout or enzyme inhibition assays to confirm their essentiality .

  • Chemical Analog Screening: Following target validation, cost-effective selection of chemical analogs can be screened for antimicrobial activity in whole-cell assays .

This systematic approach helps bridge the gap between genomics and drug discovery, potentially leading to novel antimicrobials that could overcome existing resistance mechanisms.

How can contradictory findings about RlmD be analyzed and reconciled in scientific research?

Contradictions in scientific findings about RlmD can be addressed systematically:

  • Context Specification: Many apparent contradictions in knowledge graphs arise from omitted contexts. When studying RlmD, researchers should specify experimental conditions, bacterial strains, and environmental factors .

  • Contextual Factors to Consider:

    • Population group or bacterial strain

    • Species differences (e.g., V. vulnificus vs. E. coli)

    • Dosage groups or experimental concentrations

    • Environmental conditions (pH, temperature, etc.)

  • Contradiction Detection Approaches:

    • Natural language inference techniques can help detect sentence-level contradictions

    • Domain-specific corpora for training contradiction detection models

    • Improvements in co-reference resolution across molecular biology text

  • Data Integration Strategies:

    • Knowledge graphs combining multiple sources of information

    • Incorporation of contextual information into relationship representations

    • Resolution of inconsistencies using probabilistic methods

How can RlmD be utilized in rapid detection methods for Vibrio vulnificus?

While RlmD itself is not typically the primary target for detection, understanding its role can inform novel approaches:

  • CRISPR/Cas12a Detection Systems: Rapid and sensitive diagnostic methods have been developed using recombinase-aided amplification (RAA) and CRISPR/Cas12a systems to detect V. vulnificus. These methods can detect as few as two copies of V. vulnificus genomic DNA per reaction within 40 minutes .

  • Target Selection: When designing detection systems, genes encoding essential enzymes like RlmD could potentially serve as targets for nucleic acid amplification, though more variable regions may provide better species specificity .

  • Applications:

    • Early diagnosis of human vibriosis

    • On-site detection in aquaculture

    • Food safety control

    • Environmental monitoring

What experimental design considerations are important when studying RlmD in evolutionary adaptation experiments?

Based on experimental evolution studies with related organisms, several design considerations are crucial:

  • Stress Condition Selection: Include diverse stress conditions that mimic both host and environmental conditions (iron excess/limitation, pH variation, oxidative stress, osmotic stress) .

  • Temporal Sampling Design:

    • Establish clear timepoints for sampling (e.g., day 0, 60, 120, 180, 200)

    • Monitor phenotypic changes throughout the experimental period

    • Sample at the final harvest timepoint for comparative analysis

  • Phenotypic Trait Monitoring:

    • Colony morphology

    • Biofilm formation

    • Proteolytic activity

    • Hemolytic activity

    • Metabolic profiling

  • Genetic Analysis:

    • Whole genome sequencing

    • SNP analysis

    • Detection of breakpoints, translocations, and insertions/deletions

    • Focus on recombination hotspots

  • Data Correlation: Correlate metabolic changes with genetic modifications to understand adaptation mechanisms, as shown in Table 3 from the V. cholerae study .

Why do some bacteria use multiple enzymes for rRNA modifications while others use a single enzyme?

The evolutionary divergence in rRNA modification strategies reveals interesting biological adaptations:

  • Specialization vs. Multifunctionality: In E. coli, three separate enzymes (TrmA, RlmC, and RlmD) handle different methylation targets, while in B. subtilis, a single enzyme (YefA/RlmCD) performs multiple methylations .

  • Evolutionary Scenarios: One likely explanation is that an ancestral enzyme with broad specificity underwent gene duplication and subsequent specialization in some bacterial lineages. Evidence suggests YefA in B. subtilis may be closer to an archetypical m5U methyltransferase .

  • Functional Implications:

    • Specialized enzymes may allow more precise regulation

    • Multifunctional enzymes might be more resource-efficient

    • Different evolutionary pressures in different bacterial niches could drive these distinctions

  • Methodological Considerations: When studying RlmD across species, researchers should be aware of these evolutionary differences and not assume identical functionality based solely on sequence homology .

Understanding these evolutionary relationships provides insight into bacterial adaptation and may inform approaches for broad-spectrum vs. species-specific antimicrobial development.

How has RlmD evolved across different bacterial species, and what does this tell us about its importance?

The evolution of RlmD across bacterial species reveals fascinating patterns:

  • Phylogenetic Distribution: RlmD is found in most bacterial species, with variations in both sequence and specificity, indicating that rRNA modification is an ancient and important process .

  • Structural Conservation: Despite sequence variations, the core catalytic domain shows conservation, suggesting functional importance throughout evolution .

  • Specificity Shifts: The evolution of target specificity demonstrates that RlmD has undergone adaptation in different bacterial lineages, potentially responding to specific environmental pressures or ribosomal changes .

  • Archaeal Connections: Some Archaea possess related enzymes that perform similar modifications, suggesting that these RNA modification systems predate the divergence of Bacteria and Archaea .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.